Trade Bristol Myers ^BMY

Undetectable Disease Status in Myeloma Similar With Drug Therapy, Transplantation

Truist Lifts BioNTech (BNTX) Price Target After New Partnership

Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment

Bristol-Myers Squibb (NYSE:BMY) Stake Raised by Viking Fund Management LLC

Fulton Bank N.A. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by LVW Advisors LLC

Why BioNTech SE (BNTX) Skyrocketed On Monday

Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies

Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC

Bristol Myers' cancer deal is promising, but doesn't change our stance on stock yet

Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race | Morningstar

Douglas Lane & Associates LLC Sells 48,110 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Milestone Asset Management LLC

Bristol Myers to help develop cancer drug in BioNTech partnership

Bristol Myers to Pay $1.5B for BioNTech Cancer Drug Deal | Newsmax.com

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | The Manila Times

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | Morningstar

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Rhumbline Advisers

GAMMA Investing LLC Acquires 2,386,970 Shares of Bristol-Myers Squibb (NYSE:BMY)

This Week in Chancery Court: Squarespace, Bristol-Myers Squibb

BioNTech, Bristol Myers Ink Strategic Partnership To Co-Develop BNT327 For Several Solid Tumor Type

Biontech trades half of bispecific BNT-327 to BMS for potential $11B+ | BioWorld

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY) | Markets Insider

Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

Meyer Handelman Co. Sells 7,905 Shares of Bristol-Myers Squibb (NYSE:BMY)

Wealth Enhancement Advisory Services LLC Purchases 120,192 Shares of Bristol-Myers Squibb (NYSE:BMY)

Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial

Perioperative durvalumab plus chemotherapy plus new agents for resectable non-small-cell lung cancer: the platform phase II NeoCOAST-2 trial

Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 1% - Here's What Happened

Webster Bank N. A. Cuts Stake in Bristol-Myers Squibb (NYSE:BMY)

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial

Why the stock rally fizzled - plus, our latest thinking on Goldman and Bristol Myers

C3.ai, Inc. (NYSE:AI) Q4 2025 Earnings Call Transcript

Fairtree Asset Management Pty Ltd Invests $550,000 in Bristol-Myers Squibb (NYSE:BMY)

Chancellor Financial Group WB LP Purchases Shares of 8,673 Bristol-Myers Squibb (NYSE:BMY)

111 Capital Purchases New Holdings in Bristol-Myers Squibb (NYSE:BMY)

Two Sigma Investments LP Sells 4,635,617 Shares of Bristol-Myers Squibb (NYSE:BMY)

Rutgers student's internship at Goldman Sachs leads to full-time job offer | Morningstar

Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications | Morningstar

Bristol Myers Gets European Approval for Subcutaneous Opdivo | Morningstar

Halozyme Says Bristol-Myers Squibb Gets EC Approval For Opdivo SC Developed With Halozyme's ENHANZE

Top Startup and Tech Funding News - May 27, 2025

Leigh Baldwin & CO. LLC Makes New $534,000 Investment in Bristol-Myers Squibb (NYSE:BMY)

294,400 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Polar Asset Management Partners Inc.

Forum Financial Management LP Acquires 5,462 Shares of Bristol-Myers Squibb (NYSE:BMY)

Ascent Group LLC Increases Position in Bristol-Myers Squibb (NYSE:BMY)

49,748 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by GF Fund Management CO. LTD.

Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial

Is It Crohn's or Ulcerative Colitis? IBD Types Are Similar but Not the Same

Hall Capital Management Co. Inc. Purchases Shares of 5,815 Bristol-Myers Squibb (NYSE:BMY)

10,000 Shares in Bristol-Myers Squibb (NYSE:BMY) Purchased by Aurdan Capital Management LLC

Leigh Baldwin & CO. LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)

846 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Fourth Dimension Wealth LLC

Vise Technologies Inc. Has $2.54 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)

JT Stratford LLC Buys 22,929 Shares of Bristol-Myers Squibb (NYSE:BMY)

Inspire Trust Co. N.A. Sells 45,500 Shares of Bristol-Myers Squibb (NYSE:BMY)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Increases Stake in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Decreased by Public Employees Retirement System of Ohio

Css LLC Il Raises Stake in Bristol-Myers Squibb (NYSE:BMY)

Tidal Investments LLC Has $5.10 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Waverly Advisors LLC Purchases 18,722 Shares of Bristol-Myers Squibb (NYSE:BMY)

Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 3,196,919 Shares of Bristol-Myers Squibb (NYSE:BMY)

Wesleyan Assurance Society Sells 9,811 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Woodline Partners LP

Multiple Myeloma Market Size 2024-2035, Epidemiology, Treatment & Companies

Leica Biosystems and Bristol Myers Squibb Announce Strategic Partnership to Drive Innovation in Companion Diagnostics and Enable Precision Medicine | PressReleasePoint

In silico evaluation of the immunogenic profile of lung cancers with SMARCA4 genetic alterations

USS Investment Management Ltd Sells 46,833 Shares of Bristol-Myers Squibb (NYSE:BMY)

St. Clair Advisors LLC Buys New Shares in Bristol-Myers Squibb (NYSE:BMY)

Triglav Skladi D.O.O. Buys Shares of 28,900 Bristol-Myers Squibb (NYSE:BMY)

Multicenter phase Ib/II study of second-line durvalumab and tremelimumab in combination with paclitaxel in patients with biomarker-selected metastatic gastric cancer

Trump's MFN model may erode Big pharma's 50% US profits, analysts suggest

Zurich Insurance Group Ltd FI Purchases 422,804 Shares of Bristol-Myers Squibb (NYSE:BMY)

Texas Bank & Trust Co Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)

Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic | The Manila Times

Blending Traditional and Digital: How Brand Insiders Engage Today's Consumers 05/20/2025

Bristol Myers Squibb patents new BCL-6 degradation inducers | BioWorld

Suvretta Capital Management LLC Takes Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Two Sigma Advisers LP

Siemens Fonds Invest GmbH Sells 44,507 Shares of Bristol-Myers Squibb (NYSE:BMY)

Thornburg Investment Management Inc. Reduces Holdings in Bristol-Myers Squibb (NYSE:BMY)

Rafferty Asset Management LLC Acquires 21,714 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb patents new USP1 inhibitors | BioWorld

Progressive Pulmonary Fibrosis Slows With Novel Agent

Stonebrook Private Inc. Purchases 276 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Unloaded Sen. Tommy Tuberville

Second Line Capital LLC Sells 1,944 Shares of Bristol-Myers Squibb (NYSE:BMY)

Second Line Capital LLC Cuts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Shell Asset Management Co.

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by ProShare Advisors LLC

Netflix Stock Hits Record High: Could Netflix Stock Reach $1,400 in 2025?

USD/MXN Forecast: The US dollar has fallen against the Mexican peso

XRP Price Predictions: What’s Fueling the XRP Price Rally?

NXNN Stock Performance: Why NXNN Stock Gains Attention from Wall Street

Snowflake Stock Jumps on $250M AI Deal: Is SNOW a good stock to buy now?

Uber stock forecast: What is the prediction for Uber stock?

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Week ahead: Fed to hike 100bps into a recession?

AI Stock Analysis: PLTR Hits Record High as Government Deals Fuel Momentum

ACHR Stock Analysis: What’s Driving Archer Aviation's Market Performance?

Morning Note: ADP Jobs Report Eyed; BoC Rate Decision; ISM Services PMI

XRP Price Prediction: Where Will Ripple Price Be in June?

TEM stock price analysis: Why Tempus AI Stock Up Today?

Morning Note: CrowdStrike Reports; Gold Rises on Tensions; Dollar Falls Amid Trade Fears

Morning Note: Oil Jumps on Geopolitics; US JOLTs Eyed; USD/JPY Outlook

Morning Note: US-China Tensions Renew; ISM PMI Eyed; S&P 500, EURUSD Outlook